Search
for
Sort by
Research 451–480 of 1000+
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Assessment and treatment of adolescent hair loss
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Successful treatment of resistant alopecia totalis with tofacitinib
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Systemic immunotherapies
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- Alopecia areata
- In reply
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Tofacitinib in the Management of Alopecia Universalis
- Targeted immunotherapy for hair regrowth and regeneration
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Successful Treatment of Canities Subita with Baricitinib
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances